Camsing Healthcare Limited (SGX:BAC)
Singapore
· Delayed Price · Currency is SGD 0.0410
0.00 (0.00%)
Last updated: Apr 17, 2025
Camsing Healthcare Income Statement
Financials in millions SGD. Fiscal year is February - January.
Millions SGD. Fiscal year is Feb - Jan.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
| Revenue | 4.78 | 4.85 | 6.1 | 5.53 | 5.69 | Upgrade
|
| Revenue Growth (YoY) | -1.42% | -20.50% | 10.36% | -2.81% | -22.14% | Upgrade
|
| Cost of Revenue | 2.04 | 1.87 | 2.59 | 2.67 | 2.31 | Upgrade
|
| Gross Profit | 2.74 | 2.98 | 3.51 | 2.86 | 3.38 | Upgrade
|
| Selling, General & Admin | 5.33 | 4.96 | 5.53 | 4.68 | 4.93 | Upgrade
|
| Operating Expenses | 5.34 | 4.96 | 5.53 | 4.68 | 4.93 | Upgrade
|
| Operating Income | -2.61 | -1.98 | -2.02 | -1.82 | -1.56 | Upgrade
|
| Interest Expense | -0.32 | -0.57 | -0.48 | -0.17 | -0.18 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.05 | 0.04 | 0.06 | 0.13 | 0.1 | Upgrade
|
| EBT Excluding Unusual Items | -0.88 | -2.51 | -2.44 | -1.86 | -1.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 0.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | Upgrade
|
| Asset Writedown | - | -0.21 | 0.04 | -0.19 | -0.37 | Upgrade
|
| Other Unusual Items | - | - | - | 0.69 | 1.13 | Upgrade
|
| Pretax Income | -0.88 | -2.72 | -2.4 | -1.35 | -0.83 | Upgrade
|
| Income Tax Expense | - | - | - | -0.02 | - | Upgrade
|
| Earnings From Continuing Operations | -0.88 | -2.72 | -2.4 | -1.33 | -0.83 | Upgrade
|
| Minority Interest in Earnings | - | 0 | -0 | 0 | 0 | Upgrade
|
| Net Income | -0.88 | -2.72 | -2.41 | -1.33 | -0.83 | Upgrade
|
| Net Income to Common | -0.88 | -2.72 | -2.41 | -1.33 | -0.83 | Upgrade
|
| Shares Outstanding (Basic) | 90 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 90 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 200.00% | - | 0.07% | -0.07% | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.09 | -0.08 | -0.04 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.09 | -0.08 | -0.04 | -0.03 | Upgrade
|
| Free Cash Flow | -1.59 | 0.33 | -0.73 | 0.64 | 2.06 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | 0.01 | -0.02 | 0.02 | 0.07 | Upgrade
|
| Gross Margin | 57.27% | 61.46% | 57.51% | 51.70% | 59.35% | Upgrade
|
| Operating Margin | -54.46% | -40.85% | -33.03% | -32.93% | -27.33% | Upgrade
|
| Profit Margin | -18.42% | -56.10% | -39.41% | -24.01% | -14.55% | Upgrade
|
| Free Cash Flow Margin | -33.14% | 6.70% | -11.96% | 11.54% | 36.19% | Upgrade
|
| EBITDA | -2.56 | -1.9 | -1.92 | -1.72 | -1.35 | Upgrade
|
| EBITDA Margin | -53.56% | -39.18% | -31.51% | -31.09% | -23.71% | Upgrade
|
| D&A For EBITDA | 0.04 | 0.08 | 0.09 | 0.1 | 0.21 | Upgrade
|
| EBIT | -2.61 | -1.98 | -2.02 | -1.82 | -1.56 | Upgrade
|
| EBIT Margin | -54.46% | -40.85% | -33.03% | -32.93% | -27.33% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.